Perioperative Blood Product Use: A Comparison Between HeartWare and HeartMate II Devices Nicholas A. Haglund, MD, Mary E. Davis, MS, CCRP, Nicole M. Tricarico, BS, Rashid M. Ahmad, MD, Thomas G. DiSalvo, MD, MPH, Mary E. Keebler, MD, Kelly H. Schlendorf, MD, MHS, Mark A. Wigger, MD, John M. Stulak, MD, Simon Maltais, MD, PhD The Annals of Thoracic Surgery Volume 98, Issue 3, Pages 842-849 (September 2014) DOI: 10.1016/j.athoracsur.2014.05.016 Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Postoperative chest tube output: acute and chronic phases. Total chest tube (CT) output was increased in patients implanted with a HeartMate II (HM II) versus a HeartWare (HW) device. Postoperative CT output was greatest during the first 3 days (acute phase) after continuous-flow left ventricular assist device (CF-LVAD) implantation. (HVAD = heart ventricular assist device.) The Annals of Thoracic Surgery 2014 98, 842-849DOI: (10.1016/j.athoracsur.2014.05.016) Copyright © 2014 The Society of Thoracic Surgeons Terms and Conditions